WHAT Representatives from the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., will be available at the BIO 2005 Annual International Convention to discuss how the biotechnology industry can partner in the company's innovative approaches to develop safe, effective and affordable new medicines for people with infectious disease in developing countries.

The company's first drug is on track for submission to the Indian regulatory authority by the end of this year. OneWorld Health's pipeline includes drugs for neglected infectious diseases, including visceral leishmaniasis (VL), Chagas disease, malaria and diarrhea. The company recently announced it received Orphan Drug Designation for paromomycin to treat visceral leishmaniasis (VL) from the two leading regulatory agencies in the world, the U.S. Food and Drug Administration and the European Agency for the Evaluation of Medicinal Products.

More information is available at www.oneworldhealth.org

WHEN June 20-22
Mon. 9:30-5:00, Tues. 10:00-6:30, Wed. 10:00-3:30

WHERE BIO 2005 Annual International Convention, Philadelphia
Booth #564 (in California Section)

'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
6-Jun-2005

Page: 1
Related biology news :

1. Weizmann Institute scientists discover a control mechanism for metastasis
2. UCLAs California NanoSystems Institute partners with Abraxis BioScience
3. Wiley extends publishing partnership with the American Institute of Chemical Engineers
4. Biodesign Institute leads innovative project to prevent cancer
5. DOE Joint Genome Institute secures long-term lease on production genomics facility
6. Weizmann Institute scientists develop a general control switch for protein activity
7. Research without borders: Head of Santa Fe Institute to address NSF
8. Stowers Institutes Workman Lab demonstrates mechanism for decoding histone modification marks
9. The Institute of Ecosystem Studies recognized by the Wildlife Society
10. 2007 Wistar Institute Science Journalism Award winner announced
11. UCLA AIDS Institute researchers find a peptide that encourages HIV infection